血栓式微血管病变 在COVID-19疫苗接种后
Rahaf Salem1, Ibrahim Al Mulla2, Noure Alhouda3
1Department of Internal Medicine, King Abdulaziz Medical City, Riyadh, SAU.
Cureus
|June 17, 2024
概括
接种COVID-19疫苗与罕见的血栓塞栓事件有关. 这份病例报告详细介绍了两名在COVID-19疫苗接种后患有血栓性微血管病的患者,强调了对疫苗诱导血栓的进一步研究的需要.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19呈现出各种症状,包括严重的血栓栓塞并发症,增加了发病率和死亡率.
- 虽然疫苗可以预防COVID-19,但在接种疫苗后报告了罕见的血栓栓塞事件.
- 在COVID-19感染和接种疫苗后,血栓形成的病理生理学尚未完全理解,其中涉及过度炎症和免疫反应.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:24Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831